A Brief History of Breast Cancer : Part I: Surgical domination reinvented by Lakhtakia, Ritu
Sultan Qaboos University Med J, May 2014, Vol. 14, Iss. 2, pp. e166-169, Epub. 7TH Apr 14
Submitted 26TH Feb 14
Revision Req. 9TH Mar 14, Revision Recd. 10TH Mar 14
Accepted 10TH Mar 13
The female breast has always been a symbol of beauty, fertility and femininity. In disease, however, it has challenged physicians 
since antiquity. Surgery, which ruled the roost for 
cancer therapy, inevitably caused disfigurement when 
the knife was applied to the breast. The history of breast 
cancer is a complex maze of attempts to understand 
the wily nature of this hormone-responsive cancer and 
the will of physicians to conquer it by physical removal 
(surgery), cell destruction (chemo-radiotherapy) or 
targeted therapy to cell receptors (biomodulation). It 
is also a saga of intense exploration to find the tools 
to enable early diagnosis. The story of the domination 
of surgery over two millennia and its evolution from 
fatalistic choices to minimal damage is told in the 
succeeding paragraphs. The pathobiological basis of 
breast cancer that changed chirurgical practice from 
crudity to finesse is woven through the narrative.
Beliefs and Practices Through 
Antiquity
It is not surprising that written records and illustrations 
of breast cancer date back to antiquity since the 
location of the organ permitted easy identification. 
The Edwin Smith Surgical Papyrus, dating back to 
3,000–2,500 B.C., and possibly attributable to Imhotep 
(the Egyptian physician-architect), provides authentic 
accounts of breast cancer. A case was deemed 
incurable if the disease was “cool to touch, bulging and 
spread all over the breast”.1 In ancient Greece, a divinity 
was exhorted to offer relief from breast maladies, as 
evidenced by votive offerings in the shape of breasts 
in Greek temples that housed Asclepius, the god of 
medicine.2 Carcinoma (karkinoma), scirrhous (hard, 
Greek skirros) and cacoethes (malignant disease, 
Greek kakoethes) in the medical lexicon owe their 
origins to Hellenistic writings. Hippocrates’ theory 
in c. 400 B.C. of the imbalance of humours (blood, 
phlegm, and yellow and black bile) as a cause of 
disease, and his classic descriptions of the progressive 
stages of breast cancer, represent early hypotheses on 
the cause of cancer.3 
Leonides of Alexandria, in 1st century A.D., 
preserving the Greek traditions, boldly and skillfully 
detailed his approach of incision and cautery.4 His 
stipulation of leaving a wide margin of excision and 
only removing tumours of limited extent, foreshadows 
the oncological principles of contemporary surgical 
practice.5 Galen, attributing breast cancer in A.D. 
200 to the accumulation of black bile in the blood, 
concluded that it was a systemic disease.6 These 
ancient physicians postulated that the cessation of 
menstruation was somehow linked to cancer; in fact it 
probably had to do with the association of cancer with 
old age. In line with this theory, Galen allowed surgical 
wounds to bleed freely to get rid of the black bile and 
frowned on the use of ligatures. The word ‘crab’ for 
cancer was coined by him to illustrate the dilated veins 
radiating from the tumour.5
Surgical Stagnation in the 
Middle Ages
Between 476 and 1,500 A.D. medical progress was 
inextricably intertwined with the emerging religious 
philosophies. Early Christian beliefs favoured faith 
healing and miracles over surgery, which was perceived 
as barbaric. Islamic emergence revived Greek medicine 
and, through meticulous translations, saved medical 
knowledge for posterity. Avicenna (Ibn Sina, Persia) 
and Albucasis (Abu Al-Qasim Al-Zahrawi, Spain) in 
the 10th century and Maimonides (Spain) in the 12th 
century were Arab physicians of renown, forming a 
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trio of exemplars who spread medical excellence to 
the boundaries of the expanding Islamic conquests;2 
Albucasis was a strong advocate of the use of cautery 
in surgery.7 The use of caustic pastes to annihilate the 
tumour and render it operable, is reminiscent of the 
same logic for using chemotherapy for large breast 
cancers today. Unique instruments to aid in the rapid 
removal of breast tumours were introduced into the 
surgical armamentarium by Albucasis, Henri de 
Mondeville (‘father’ of French surgery, 13th century) 
and Guy de Chauliac (France, 14th century).
Renaissance: A celebration 
of arts and the emergence of 
surgery
The 16th to 18th centuries not only bred artistic creativity 
but proved to be the golden age for the emergence of 
surgery. The craft of surgery was unshackled from 
its previous conjoint status with the barber’s trade 
and grew on the shoulders of a strong anatomical 
exploration of the human body by Andreas Vesalius 
in 16th century Belgium. In 18th century England and 
France, respectively, Cooper’s eponymous ligaments 
of the breast and Sappey’s subareolar plexus of 
lymphatics ushered in an era that revisited the origins 
and spread of breast cancer.8,9 In the same era, John 
Hunter (the Scottish ‘father’ of investigative surgery) 
replaced ‘black bile’ with lymph as the cause of 
breast cancer. A multitude of theories ranging from 
inspissated milk, trauma, personality type, exposure 
to air and infection were fed into the cauldron of 
carcinogenesis. The observation of the disease 
within families was naturally attributed to infection. 
Amidst this chaotic search for the truth, accounts of 
heroic surgeries from simple lumpectomies to radical 
removal of the pectoralis, enliven medical records.4 
These are rendered more vivid and admirable when it 
is recalled that in the absence of anaesthesia, skill and 
speed were the sole attributes of a successful surgeon. 
It is also a grim reminder that surgery was the solitary 
modality for hope of relief with anecdotal incidences 
of cure. More conservative compatriots used ligatures 
or lead plates to strangulate the tumours, preferring 
them to the horrors of breast amputation.
Nineteenth Century: The 
golden age of surgery
The surgical discipline rapidly grew on the bedrock of 
a spate of discoveries that rendered it safer with a good 
outcome for the patient. Disinfection and sterilisation 
and the use of sterile gloves were the first landmark 
events. General anaesthesia revolutionised the 
surgeon’s ease (and indeed the patient’s too!). Although 
in 1818 James Blundell attempted blood transfusion in 
postpartum haemorrhage, safe transfusions would be 
achieved only at the dawn of the 20th century with the 
discovery of blood groups by Karl Landsteiner. Against 
this background, seminal contributions to cancer 
came from the microscopic identification of normal 
cells and their cancerous brethren all the way from 
Hooke in 17th century England to Müller and Virchow 
in 19th century Germany. Müller dismissed the 
humoral theory of the origin of cancer, declaring that 
cancers were composed of living cells and suggesting 
that metastasis was due to spread of these cells.6 The 
demonstration that breast cancer spread along the 
lymphatics to the guardian axillary nodes was to form 
the basis of a variety of excision techniques. Unique 
forms of spread leading to the clinical manifestations 
of carcinoma en cuirasse or peau d’orange and Paget’s 
disease would demand alternative ways of approaching 
treatment. 
The middle years of the 19th century celebrated the 
newly acquired surgical freedom with bold and radical 
surgeries. The en bloc resections of Charles Moore in 
London,10 and Kuster and Volkmann in Germany ran 
a parallel course.11 Axillary lymph node dissections 
as part of the philosophy of extermination were 
performed in 1882 by William Banks in Liverpool, 
UK.12 While they may appear particularly mutilating 
today, they provided a unique opportunity to study 
the disease spread. Breast cancer surgery at the turn 
of the century came to be synonymous with the name 
of William S. Halstead, Professor of Surgery at Johns 
Hopkins hospital in Baltimore, USA. His radical 
mastectomy (first reported in 1894) with its emphasis 
on removing tissues in one piece to prevent spread and 
removal of the pectoralis major to prevent recurrence, 
became the undisputed path that generations of 
surgeons trod with diligence.13 “The suspected tissue 
should be removed in one piece, (1) lest the wound 
become infected by the division of tissues invaded by 
the disease or of lymphatic vessels containing cancer 
cells, and (2) because shreds or pieces of cancerous 
tissue might readily be overlooked in the piecemeal 
extirpation.”14
These strict rules for non-violation of the tumour 
area precluded a preoperative biopsy to confirm 
whether the patient had a cancer at all: such was the 
strength of a skilled clinical diagnosis! Another age-
old practice that came to a close was to leave the 
excised surgical wound open to granulate. The use of 
ligatures now allowed better wound healing through 
low infection rates. 
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manifestation of axillary lymph node dissections, to 
the annals of surgical history. 
Once surgeons lead the revolution towards 
minimising extirpation, the first faltering steps towards 
restoring cosmesis were taken by Verneuil, a French 
surgeon who transferred autologous tissue from 
the normal breast to the diseased one in 1887.23This 
released the floodgates for a variety of innovative 
autologous and synthetic materials offering a restored 
shape that could even outdo nature’s original creation. 
Muscle, myocutaneous flaps, lipomas and omentum 
were natural choices. The transverse rectus abdominis 
myocutaneous flap (TRAM) introduced in 1979 by 
Holmstrom has stood the test of time, undergoing 
several modifications in its evolution.24 Prosthetic and 
synthetic options brought industry and commerce 
into the fray: petroleum jelly, glass balls, ivory, rubber, 
polyvinyl alcohol sponge and silicone— the list is ever 
growing!
Surgical domination over the treatment of breast 
cancer held sway for the millennia, ever since the first 
recorded medical literature. The hope for a cure by 
the radical removal of a diseased organ was always 
counterbalanced by fascinating and fearsome accounts 
of surgery sans anaesthesia as a physically and 
psychologically mutilating therapeutic option. While 
nowhere near its nadir, surgery remains at the heart 
of management in a multimodality setting. Instead 
of annihilation it now provides succour to the breast 
cancer survivor thus balancing cure and cosmesis.
Lessons from the History of 
Surgery in Breast Cancer
There are three lessons to be gained from the history 
of surgery in breast cancer. First, to delve into history 
is to rediscover buried insights: Galen’s perceptive 
assessment that breast cancer is a systemic disease 
was echoed two millennia later in Fisher’s 20th century 
observations. Second, the evolution of therapeutic 
weaponry raises the fortunes of medical disciplines (as 
antisepsis and anaesthesia did for surgery) or minimises 
their supremacy as stand-alone choices for panacea 
or cure (as chemoradiotherapy did for surgery). 
Third, stooping to conquer is the mark of survival in 
contemporary medical practice. Surgery has won the 
day by adapting and playing a complementary role in 
modern cancer management as a stylised, scientific 
and patient-friendly craft.
Twentieth Century: Surgery 
reinvents itself 
The hormone dependency of breast cancer was 
initially hypothetical, through the observation that the 
disease was aggressive in younger women. Beatson 
ignited the era of endocrine surgery in 190615—long 
before the discovery of estrogen receptors by Jensen 
in 196716 and oopherectomy and adrenalectomy 
(to achieve castration) came in vogue. These rather 
drastic methods were gradually overtaken by estrogen 
receptor modulators, luteinising hormone-releasing 
agonists and aromatase inhibitors.
Halstead’s legacy was, for a while, preserved by 
Margottini and Veronesi in Milan who additionally 
removed internal mammary nodes and others who 
extended the scope of ‘radicality’ to supraclavicular 
and mediastinal nodes. However, the late 19th and 
early 20th centuries gradually heralded the demise of 
the adage: big surgeons make big incisions (and hence 
perform big surgeries). Patey and Handley from 
London and Auchincloss Jr. of New York ushered in 
a movement that ‘modified’ the radical mastectomy 
and preserved the pectoralis major.17 Rapid advances 
in medical radiation as a means of killing cancer cells 
and new forms of chemotherapy that did the same, 
but also achieved medical castration or targeted 
mutated tumour receptors, forced a rethink of cancer 
management strategies. These were coupled with the 
burgeoning knowledge of the biological behaviour of 
breast cancer and the less-than-guaranteed success of 
surgery alone. Early cancer detection of smaller lesions 
by mammography added a new dimension to surgical 
management. 
The clarion call to reorient to limited surgery 
came from the surgery fraternity. Bernard Fisher, 
Professor of Surgery at the University of Pittsburgh, 
revived Galen’s ancient belief that breast cancer was a 
systemic disease. Large randomised controlled clinical 
trials like the National Surgical Adjuvant Breast and 
Bowel Project (NSABP), published in 1989, provided 
scientific support.18 It is ironic that the disbandment 
of the radical Halstedian approach, the institution of 
trials and the acceptance of neoadjuvant therapy were 
the brainchildren of a surgeon! Veronesi from Italy and 
many others supported the notion of limited surgery 
complemented by adjuvants.19 Surgery reinvented 
itself to join hands with the other modalities. Since 
the close of the 20th century breast conservation and 
breast reconstruction—combined, where necessary, 
with sentinel node dissection—have held sway.20–22 
The removal of only selected ‘sentinel’ nodes (those 
to which the tumour had spread) would relegate 
the swollen lymphoedematous arm, a distressing 
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